Thermo Fisher Scientific’s Clinical Research Business Receives “Best Lab” Recognition at Vaccine Industry Excellence Awards

WILMINGTON, N.C. (April 12, 2023) – The PPD clinical research business of Thermo Fisher Scientific received the Best Central/Specialty Laboratory Award at the 16th annual Vaccine Industry Excellence (ViE) Awards during the 2023 World Vaccine Congress in Washington, D.C. The award recognizes success in helping customers develop safe and effective vaccines to improve health and save lives.   

The PPD® Laboratory services team of the clinical research business has more than 30 years’ experience as a crucial provider of successful vaccine testing programs at every stage of vaccine development. Additionally, the PPD vaccine sciences lab, with more than 90,000 square feet of lab space for vaccine programs, offers concomitant and efficacy studies for Phase I through Phase III clinical trials and post-licensure studies.

“We are dedicated to delivering a cohesive scientific package with dedicated project managers and scientific teams working collaboratively to successfully achieve our customers’ goals,” said Chris Forsdyke, vice president, vaccine sciences lab, clinical research, Thermo Fisher Scientific. “Our focus is to provide creative solutions that deliver the right, timely, high-quality data to meet regulatory expectations and shorten development cycles, while accelerating time to market for life-changing vaccines.”

The PPD clinical research business offers a wide range of high-value, advanced analytical testing services, including bioanalytical, biomarkers, central lab, GMP and vaccine sciences. Customers benefit from laboratory services and data integration capabilities that help accelerate pharmaceutical development for small molecules, biologics, vaccines, and cell and gene therapies.

In addition to premier laboratory capabilities in vaccine research, the business offers customers comprehensive clinical development services for vaccine development, with more than 2,000 vaccine experts and deep expertise in trial design, data analytics, project management, laboratory testing, pharmacovigilance and regulatory requirements.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit

Media Contact Information
Nadine Maeser